Published in Gene Therapy Weekly, December 13th, 2001
"Hammerhead ribozymes have recently gained attention as potential tools to inhibit viral infection, for which there are no general effective therapies available," Y. Feng and colleagues from the Chinese Academy of Sciences in China noted in a recent issue of the Journal of Gastroenterology and Hepatology.
Ribozymes can cut and even splice RNA chains. Feng and fellow researchers used hammerhead ribozymes (RZC) to disrupt...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly